Innovative Eyewear Inc (LUCY)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch LUCY
See up to 3 months of LUCY. The 7-day demo opens the 1M and 3M ranges and puts LUCY on your watchlist.
Start 7-day demoLatest LUCY insider trades
About Innovative Eyewear Inc (LUCY)
Innovative Eyewear Inc files with the SEC under CIK 0001808377 and is classified as ophthalmic goods. We track it alongside the rest of the Health Care sector. It filed a registration statement with the SEC on 23 July 2026 and has not yet priced an offering.
LUCY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 82,466 | $73K |
| Grant or award | 15 | 549,466 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
LUCY insider transactions (Form 4)
3314 Form 4 filings on record, the earliest from Jan 12, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oswald Gayle - Officer | Grant or award | Common Stock | 60,000 footnote F1 | $0.00 | - | |
| ||||||
 Konrad Dabrowski - Officer | Grant or award | Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Joaquin Abondano - Officer | Grant or award | Common Stock | 90,000 footnote F1 | $0.00 | - | |
| ||||||
| Harrison R. Gross - Officer | Grant or award | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| David Eric Cohen - Officer | Grant or award | Common Stock | 60,000 footnote F1 | $0.00 | - | |
| ||||||
| Oswald Gayle - Officer | Grant or award | Common Stock | 16,233 | $0.00 | - | |
| Oswald Gayle - Officer | Open-market sale | Common Stock | 7,574 | $1.07 footnote F1 | $8K | |
| Oswald Gayle - Officer | Grant or award | Common Stock | 16,233 | $0.00 | - | |
| Oswald Gayle - Officer | Open-market sale | Common Stock | 7,959 | $0.67 footnote F2 | $5K | |
| ||||||
| Konrad Dabrowski - Officer | Grant or award | Common Stock | 20,900 | $0.00 | - | |
| Konrad Dabrowski - Officer | Open-market sale | Common Stock | 6,692 | $1.06 | $7K | |
| Konrad Dabrowski - Officer | Grant or award | Common Stock | 20,900 | $0.00 | - | |
| Konrad Dabrowski - Officer | Open-market sale | Common Stock | 6,935 | $0.69 footnote F1 | $5K | |
| ||||||
| Joaquin Abondano - Officer | Grant or award | Common Stock | 14,800 | $0.00 | - | |
| Joaquin Abondano - Officer | Open-market sale | Common Stock | 4,779 | $1.05 | $5K | |
| Joaquin Abondano - Officer | Grant or award | Common Stock | 14,800 | $0.00 | - | |
| Joaquin Abondano - Officer | Open-market sale | Common Stock | 5,020 | $0.68 footnote F1 | $3K | |
| ||||||
| Harrison R. Gross - Officer | Grant or award | Common Stock | 24,600 | $0.00 | - | |
| Harrison R. Gross - Officer | Grant or award | Common Stock | 24,600 | $0.00 | - | |
| Harrison R. Gross - Officer | Open-market sale | Common Stock | 13,764 | $1.07 footnote F1 | $15K | |
| Harrison R. Gross - Officer | Open-market sale | Common Stock | 8,252 | $0.69 footnote F2 | $6K | |
| Harrison R. Gross - Officer | Open-market sale | Common Stock | 5,722 | $0.71 footnote F3 | $4K | |
| ||||||
| David Eric Cohen - Officer | Grant or award | Common Stock | 18,200 | $0.00 | - | |
| David Eric Cohen - Officer | Open-market sale | Common Stock | 5,913 | $1.04 | $6K | |
| David Eric Cohen - Officer | Open-market sale | Common Stock | 1,860 | $1.11 | $2K | |
| David Eric Cohen - Officer | Open-market sale | Common Stock | 1,860 | $1.17 | $2K | |
| David Eric Cohen - Officer | Grant or award | Common Stock | 18,200 | $0.00 | - | |
| David Eric Cohen - Officer | Open-market sale | Common Stock | 6,136 | $0.68 footnote F1 | $4K | |
| ||||||
| Harrison R. Gross - Officer | Open-market purchase | Common Stock | 1,500 | $1.32 | $2K | |
| Oswald Gayle - Officer | Open-market purchase | Common Stock | 700 | $1.66 | $1K | |
| Oswald Gayle - Officer | Open-market purchase | Common Stock | 300 | $1.69 | $507 | |
| Harrison R. Gross - Officer | Open-market purchase | Common Stock | 1,500 | $1.60 | $2K | |
| Konrad Dabrowski - Officer | Open-market purchase | Common Stock | 1,300 | $1.58 | $2K | |
Item 3.01
Item 2.02, 9.01
Item 1.01, 3.02, 8.01, 9.01
Recent LUCY Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Joaquin Abondano | Officer | 3,912 | $3K | View on EDGAR | |
| Joaquin Abondano | Officer | 631 |
LUCY insider trading FAQ
What is the latest insider trade for LUCY?
Innovative Eyewear Inc (LUCY) had 10 insider filings in the last 90 days, with the most recent on 2 November 2026. The full record for LUCY runs to 14 Form 4 filings, the earliest from 12 January 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LUCY stock?
No insider purchases of LUCY were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling LUCY stock?
13 insider sales of LUCY were filed in the last 90 days, totaling $73K.
Where can I see LUCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LUCY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Oswald Gayle view on EDGAR
- - Konrad Dabrowski view on EDGAR
- - Joaquin Abondano view on EDGAR
- - Harrison R. Gross view on EDGAR
- - David Eric Cohen view on EDGAR
- - Oswald Gayle view on EDGAR
- - Konrad Dabrowski view on EDGAR
- - Joaquin Abondano view on EDGAR
- - Harrison R. Gross view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where LUCY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LUCY with a 7-day demo
- LUCY on your watchlist
- Every LUCY Form 4 filing on record
- Up to 3 months of LUCY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
